Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.
复制标题
DOI:
10.1038/s41409-020-0858-9
复制
发表时间:
2020-10
影响因子:
4.8
通讯作者:
Marsh SGE
中科院分区:
文献类型:
--
作者:
Bultitude WP;Schellekens J;Szydlo RM;Anthias C;Cooley SA;Miller JS;Weisdorf DJ;Shaw BE;Roberts CH;Garcia-Sepulveda CA;Lee J;Pearce RM;Wilson MC;Potter MN;Byrne JL;Russell NH;MacKinnon S;Bloor AJ;Patel A;McQuaker IG;Malladi R;Tholouli E;Orchard K;Potter VT;Madrigal JA;Mayor NP;Marsh SGE
The reported influence of donor Killer-cell Immunoglobulin-like Receptor (KIR) genes on the outcomes of haematopoietic cell transplantation (HCT) are contradictory, in part due to diversity of disease, donor sources, era and conditioning regimens within and between different studies. Here, we describe the results of a retrospective clinical analysis establishing the effect of donor KIR motifs on the outcomes of 119 HLA-matched, unrelated donor HCT for adult acute myeloid leukaemia (AML) using myeloablative conditioning (MAC) in a predominantly T cell deplete (TCD) cohort. We observed that HCT involving donors with at least one KIR B haplotype were more likely to result in non-relapse mortality (NRM) than HCT involving donors with two KIR A haplotypes (p=0.019). Upon separation of KIR haplotypes into their centromeric (Cen) and telomeric (Tel) motif structures, we demonstrated that the Cen-B motif was largely responsible for this effect (p=0.001). When the cause of NRM was investigated further, infection was the dominant cause of death (p=0.006). No evidence correlating donor KIR B haplotype with relapse risk was observed. The results from this analysis confirm previous findings in the unrelated, TCD, MAC transplant setting and imply a protective role for donor-encoded Cen-A motifs against infection in allogeneic HCT recipients.
登录
查看更多内容
影响因子:
20.3
作者:
Kollman, Craig;Spellman, Stephen R.;Eapen, Mary
通讯作者:
Eapen, Mary
影响因子:
20.3
作者:
Cooley, S;McCullar, V;Miller, JS
通讯作者:
Miller, JS
影响因子:
20.3
作者:
Cooley, Sarah;Trachtenberg, Elizabeth;Weisdorf, Daniel J.
通讯作者:
Weisdorf, Daniel J.
影响因子:
4.4
作者:
Fischer, Johannes C.;Ottinger, Hellmut;Uhrberg, Markus
通讯作者:
Uhrberg, Markus
DOI:
10.1016/s1470-2045(12)70004-9
发表时间:
2012-04
期刊:
The Lancet. Oncology
影响因子:
--
作者:
Fleischhauer K;Shaw BE;Gooley T;Malkki M;Bardy P;Bignon JD;Dubois V;Horowitz MM;Madrigal JA;Morishima Y;Oudshoorn M;Ringden O;Spellman S;Velardi A;Zino E;Petersdorf EW;International Histocompatibility Working Group in Hematopoietic Cell Transplantation
通讯作者:
International Histocompatibility Working Group in Hematopoietic Cell Transplantation